Welcome to the Clara Nahmias’ lab Homepage
![]() |
||||
![]() |
Clara Nahmias team is interested in studying cell-cell communication in normal and pathological situations, with a particular focus on the role of the angiotensin/ATIP axis and the microtubule cytoskeleton in breast cancer. Seminal work of the team identified a novel family of proteins (ATIPs) initially isolated as interacting partners of the AT2 receptor. Recent studies led to the discovery that ATIP3 is a new anti-cancer molecule and a promising target for personalized therapies of aggressive breast cancer. |
|||
Clara Nahmias was awarded the ‘Prix du Ruban Rose Avenir’ in 2010 for these studies. This studies were recently highlighted in the Inserm Website: "Breast Cancer: a protein prevents metastasis" > Read Scientific news > Read |
Clara Nahmias Interview
Presentation of the ATIP3 project by Clara Nahmias